Arcturus Therapeutics Holdings (ARCT) Equity Ratio (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) has disclosed Equity Ratio for 8 consecutive years, with 0.79 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio rose 12.68% year-over-year to 0.79, compared with a TTM value of 0.79 through Dec 2025, up 12.68%, and an annual FY2025 reading of 0.79, up 12.68% over the prior year.
- Equity Ratio was 0.79 for Q4 2025 at Arcturus Therapeutics Holdings, down from 0.8 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.8 in Q3 2025 and bottomed at 0.5 in Q3 2022.
- Average Equity Ratio over 5 years is 0.65, with a median of 0.66 recorded in 2024.
- Peak annual rise in Equity Ratio hit 210.95% in 2021, while the deepest fall reached 30.2% in 2021.
- Year by year, Equity Ratio stood at 0.58 in 2021, then rose by 3.31% to 0.6 in 2022, then increased by 8.07% to 0.65 in 2023, then increased by 7.98% to 0.7 in 2024, then increased by 12.68% to 0.79 in 2025.
- Business Quant data shows Equity Ratio for ARCT at 0.79 in Q4 2025, 0.8 in Q3 2025, and 0.75 in Q2 2025.